The Latest SPAC News and Rumors: June 13, 2023


The Latest SPAC News and Rumors: June 13, 2023

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News:  VAM SPAC to take Supermoney public, SPAC listings gain momentum in Korea, and Starton Therapeutics receives authorization from FDA

Former Bulgari chief’s SPAC agrees deal for comparison site Supermoney

Supermoney and Dutch special purpose acquisition company VAM SPAC have signed a binding accord aimed at taking the online price comparison provider public, the companies said on Monday.

Shareholders of Supermoney, which offers price comparison and technology services mainly in the energy, gas and telecoms sectors, will buy a majority stake in VAM SPAC, which in turn will take 100% of the broker’s capital.


Large SPAC listings gain momentum in Korea

The Korean SPAC market with typical offerings of around 10 billion won ($800,000) is now witnessing consecutive listings of large-scale SPACs with over 30 billion won.

According to sources on Monday, KB Securities Co. is conducting book building for KB SPAC No. 24, which has a public offering size of around 32 billion won.

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

Starton Therapeutics Inc., a clinical stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today provided updates on its Phase 1b STAR-LLD clinical trial of its investigational continuous delivery lenalidomide in multiple myeloma.

Starton has signed an agreement for a business combination with Healthwell Acquisition Corp. I (Nasdaq: HWEL).